BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33099912)

  • 1. Efficacy of synchronous stereotactic radiotherapy with temozolomide combined with whole brain radiotherapy in treating brain metastases originating from non-small cell lung cancer.
    Liu P; Ren R; You D; Liu J
    J BUON; 2020; 25(4):1771-1778. PubMed ID: 33099912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
    Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases.
    Zhu Y; Fu L; Jing W; Guo D; Kong L; Yu J
    Thorac Cancer; 2018 Sep; 9(9):1121-1128. PubMed ID: 29947170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysis.
    Han J; Qiu M; Su L; Wu C; Cheng S; Zhao Z; Li D; Wang M; Tao W; Du S
    Thorac Cancer; 2021 Dec; 12(23):3177-3183. PubMed ID: 34704360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis.
    Duan H; Zheng SY; Zhou T; Cui HJ; Hu KW
    Medicine (Baltimore); 2020 Jan; 99(5):e18455. PubMed ID: 32000358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.
    Xin Y; Guo W; Yang CS; Huang Q; Zhang P; Zhang LZ; Jiang G
    Cancer Med; 2018 Apr; 7(4):981-990. PubMed ID: 29516684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide chemotherapy combined with radiotherapy versus radiotherapy alone after surgery in patients with high-risk low-grade gliomas.
    Hou Y; Huan Y; Zhang Y; Liu X; Li Y
    J BUON; 2021; 26(3):977-983. PubMed ID: 34268962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
    Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
    Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
    Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
    Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
    Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
    Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II Study of the Efficacy and Safety of High-dose Pemetrexed in Combination with Cisplatin
    He Q; Bi X; Ren C; Wang Y; Zou P; Zhang H; Chi N; Xiu C; Wang Y; Tao R
    Anticancer Res; 2017 Aug; 37(8):4711-4716. PubMed ID: 28739776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
    Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
    Wang J; Huang Y; Zhao F; Chen J; He L; Liu Z; Pei Y; Wei Z; Li R; Ai P; Peng X
    J Neurooncol; 2022 Nov; 160(2):433-443. PubMed ID: 36357822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
    Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
    Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.